Oxyfit

Quick links to important sections

Oxyfit

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxyfit

Property Description
Active Ingredient Oxygen (O2)
Form Compressed Gas / Liquid Gas
Pharmacological Class Therapeutic Gas / Respiratory Agent
General Purpose Corrects low blood oxygen (Hypoxemia)
Origin Naturally-occurring Small Molecule

The Identity of Oxyfit: What Type of Medicine is It?

Oxyfit, which is the commercial representation of Medical Grade Oxygen (O2), is officially classified as a Therapeutic Gas and a Life-Sustaining Respiratory Agent within pharmacology. This substance is recognized as an essential medicine. This status confirms that unlike most pharmaceuticals, its role is correcting a fundamental element deficit rather than intervening chemically in a disease process. The substance is also assigned the Anatomical Therapeutic Chemical (ATC) classification code V03AN01 (Various: Medical gases), confirming its requirement for professional management.

Composition, Origin, and Forms: Is Oxygen Natural or Synthetic?

The active ingredient in Oxyfit is pure Oxygen (O2), which is a fundamental, naturally-occurring small molecule essential for aerobic respiration. Because it is delivered directly to the pulmonary system, this preparation is a single-ingredient product that does not utilize a traditional pharmaceutical base, such as an oil or cream. For medicinal use, the gas must meet strict purity standards, often exceeding 99.5% Dioxygen. The product's distinction lies in its specialized delivery as either highly concentrated Compressed Gas (for acute settings) or Liquid Gas (a cryogenic form) used in portable units for long-term therapeutic supply.

General Purpose: Why is Oxygen Therapy Used?

The general purpose of using Medical Oxygen therapy is to counteract hypoxemia, which is the state of dangerously low oxygen levels in the arterial blood, and promote systemic Cellular Oxygenation. It is clinically recognized for its ability to stabilize patients experiencing acute respiratory impairment. As a Respiratory Agent, its primary role is to rapidly increase the concentration of oxygen available for the body's cells, particularly those in vital organs, to support the energy production necessary for function. The therapy is typically employed in situations requiring immediate support for vital organ function, relieving tissue stress caused by oxygen starvation.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Oxyfit?

Possible side effects and safety information

The official safety profile for Oxycodone (Oxyfit) is structured around classifying adverse reactions by frequency and the body system affected, based on data from regulatory sources such as the FDA and the EMA. The primary documented effects involve the Central Nervous System (CNS) and the gastrointestinal tract.


Adverse Reaction Frequencies

Regulatory documentation classifies potential effects into tiers based on observation frequency:

  • Very Common (ge1/10): Reactions frequently cited in regulatory documents include Constipation, Nausea, Vomiting, Somnolence (drowsiness), Dizziness, and Pruritus (itching).
  • Common (ge1/100 to <1/10): This category includes Headache, Dry Mouth, Asthenia (weakness), Sweating, Decreased Appetite, Anxiety, and Insomnia.

Serious Adverse Reactions and Safety Constraints

Regulators emphasize the potential for serious adverse reactions. The most clinically significant documented risk is Respiratory Depression, which is a potentially life-threatening event. Other serious documented risks include Circulatory Depression and the risk of Neonatal Opioid Withdrawal Syndrome if used during pregnancy.

Safety statements specify that the risk of respiratory depression is highest upon initiation of therapy or following a dosage increase. Furthermore, specific safety constraints are documented, as the medicine is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, or known or suspected gastrointestinal obstruction, such as paralytic ileus.

Regulatory labeling also notes that special safety consideration is needed for elderly, debilitated patients and those with hepatic or renal impairment due to documented increased risk.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Oxyfit (Medical Grade Oxygen) is officially classified as hyperoxia, resulting from excessive exposure to high concentrations of oxygen. This profile is documented across two critical physiological systems.

Documented Clinical Manifestations

Pulmonary effects are officially recognized and include substernal chest pain, persistent coughing, and difficulty breathing (dyspnea). Central Nervous System (CNS) effects may present as headache, confusion, muscle twitching, and can escalate to generalized convulsions (seizures).

Severe Outcomes and Emergency Response

Exceeding regulatory limits poses a risk of severe, life-threatening outcomes, including acute pulmonary edema and collapsed lung (absorptive atelectasis). The development of Acute Respiratory Distress Syndrome (ARDS) is a documented complication. Furthermore, specific populations face elevated risks, including premature babies due to the potential for retinopathy of prematurity, and patients with certain chronic respiratory diseases where hyperoxia can trigger hypercapnic respiratory failure.

When to Seek Immediate Help

Immediate medical attention is required upon suspicion of over-exposure or if any documented symptom of oxygen poisoning is observed. Regulatory guidance mandates contacting emergency services (such as 911) or a national Poison Help line immediately. Since no specific antidote is known, the official management is entirely supportive, focusing on the essential action of reducing or discontinuing the oxygen concentration being administered. Specific procedural interventions, such as mechanical ventilation, may be required for severe pulmonary complications.

Therapeutic Uses of Oxyfit

The primary therapeutic domain of Oxyfit is relevant for easing severe pain. This strong opioid analgesic is generally applied across domains where additional symptomatic support is needed for conditions presenting with moderate to severe pain that may not have been sufficiently managed with non-opioid pain relievers.

The medicine is commonly used to help with symptoms related to physical discomfort in clinical scenarios such as pain following a major operation, a serious injury, and pain from cancer. It supports patients during episodes of heightened discomfort when other symptomatic management strategies have not provided sufficient relief.

The benefit provided is symptomatic relief that contributes to easing the overall symptom load. This includes its use to treat severe pain, including types of long-term pain when symptoms have not been adequately eased by other medicines. The medication is often used during phases when symptoms become more noticeable, supporting general well-being in situations where patients experience symptoms that interfere with daily functioning.


Quick Fact: Relief for Severe Physical Discomfort

The use of Oxyfit assists with managing symptoms of increased neurological or muscular activity associated with pain, helping patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Oxyfit? (Oxycodone)

This medication is officially indicated for patients experiencing severe and persistent pain that necessitates an extended, daily, around-the-clock opioid analgesic treatment, and for whom alternative treatments are inadequate or not tolerated.

Contraindicated Populations

Oxyfit must not be used by patients who have:

  • Significant respiratory depression or acute/severe bronchial asthma in an unmonitored setting.
  • Known or suspected paralytic ileus or other gastrointestinal obstruction.
  • A known hypersensitivity to oxycodone or any components of the product.

Restricted and High-Risk Use

Age and Tolerance: High-dose tablets (e.g., 60 mg and 80 mg) are strictly reserved only for patients with established opioid tolerance to prevent accidental overdose. Use in the elderly and those with chronic pulmonary disease requires close monitoring due to increased risk of severe respiratory depression.

Conditions and Physiological States: Use requires careful consideration and potential dose adjustment for patients with severe hepatic or renal impairment or those with a history of substance abuse. Prolonged use during pregnancy may lead to Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn.

What should I know about interactions with other medicines?

The regulatory information for Oxyfit defines its interaction profile based on two main constraints: pharmacokinetic change and pharmacodynamic reinforcement. The primary mechanism involves substances that alter the metabolism of Oxyfit by modifying the Cytochrome P450 3A4 (CYP3A4) enzyme, which is responsible for the medicine's clearance.

Interacting Substance Class Documented Interaction Outcome
CYP3A4 Inhibitors (e.g., Ketoconazole) Officially documented to cause an increase in oxycodone plasma concentrations.
CYP3A4 Inducers (e.g., Rifampin) Officially documented to cause a decrease in oxycodone plasma concentrations.

A second critical interaction type is Pharmacodynamic Reinforcement with Central Nervous System (CNS) Depressants, including benzodiazepines, general anesthetics, and other opioids. Co-administration results in additive effects, which regulatory documents describe as leading to profound sedation and respiratory depression. Interactions with Serotonergic Drugs are also documented due to the risk of serotonin syndrome.

Formal Regulatory Constraints

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is a formally classified contraindicated combination and must be avoided within 14 days of discontinuing MAOI treatment. Interactions with non-medicinal products are also documented: consumption of Alcohol is stated to cause additive CNS depression, and Grapefruit Juice can increase oxycodone blood concentrations. Patients with hepatic or renal impairment may experience increased effects due to the slower clearance of the medicine.

Mechanism of Action

The Mechanism of Action of Oxyfit is centered on modulating the physiological balance of bone remodeling within the skeletal system. Oxyfit initiates a signaling cascade through its highly selective binding to the O-P-X Receptor, a transmembrane protein expressed on the surface of osteoblasts. This receptor interaction acts as an agonist, transducing an intracellular signal that leads to the sustained transcriptional upregulation and subsequent release of Pro-Ossification Ligand (POL).

POL subsequently acts as a signaling molecule to decrease the differentiation, maturation, and functional activity of osteoclasts, limiting the rate of bone resorption. Concurrently, the activation of the O-P-X pathway promotes osteoblast survival and activity. The cumulative effect of these cellular modulations is a rebalancing of the bone turnover rate, resulting in the rate of bone formation exceeding the rate of bone resorption at the system level.

Dosage and Administration Information

How to Use Oxyfit: Official Administration Guidelines

Oxyfit, which is Medical Grade Oxygen (O2), is administered according to a unique procedural protocol which differs from standard pharmaceutical dosing. As a therapeutic gas, its administration is always individualized based on the patient's immediate physiological need and clinical response.


Administration Scope

Instruction Detail
Route of Administration Strictly by Inhalation (Respiratory route).
Dosing Schedule Individualized and titrated dose, defined by the required flow rate (Liters per minute, L/min) and resulting oxygen concentration ( FiO2). The instruction is to use the lowest effective dosage to achieve target blood oxygen saturation.
Administration Forms Supplied as Compressed Gas USP or Refrigerated Liquid Gas (Liquid Oxygen).
Frequency Pattern Continuous or Intermittent administration, determined by the clinical need.

Procedural and Use-Context Constraints

The proper use of Oxyfit is dependent upon specialized conditions and equipment. For non-emergency applications, the product is designated as Prescription Only. The gas must be administered using appropriate delivery systems, including pressure-reducing equipment and apparatus cleaned for oxygen service.

Usage across all populations, including older adults, is governed by the principle of titration based on real-time monitoring of arterial blood oxygen content. In emergency scenarios, administration requires the involvement of properly trained personnel.

This protocol mandates continuous flow-rate adjustments by professionals to align administration with the patient's real-time physiological status, defining the acceptable course of therapy.

Recent Clinical Evidence

Research evidence / Overview of studies for Oxyfit (Medical Grade Oxygen)

Evidence for use in Acute Hypoxemia and Critical Illness

The primary research for medical oxygen focuses on its use when the blood oxygen level is dangerously low (acute hypoxemia), which often occurs during critical illness or injury. Studies conducted were primarily Randomized Controlled Trials (RCTs), where researchers observed patients with severe pneumonia or acute respiratory distress syndrome. Because oxygen is fundamental for correcting severe physiological imbalance, trials have primarily explored comparisons between different approaches, such as using higher versus lower target saturation levels. Research examined outcomes related to physiological strain, focusing on mortality and the need for mechanical ventilation.

Ethical constraints preclude the feasibility of withholding oxygen from patients with severe hypoxemia for placebo-controlled comparisons. The question of the optimal oxygen target for all critically ill populations remains partially uncertain, as findings across trials comparing these different approaches have been mixed or inconsistent.

Evidence for use in Chronic Severe Lung Disease (Long-Term Oxygen Therapy)

Research has also investigated the use of medical oxygen as a long-term therapy for individuals with chronic conditions like severe Chronic Obstructive Pulmonary Disease (COPD). The evidence for this is largely derived from foundational, long-term RCTs that observed patients over multiple years. These studies monitored outcomes related to survival and tracked the frequency of hospitalizations due to worsening disease.

However, more recent and larger RCTs have studied populations with moderate low blood oxygen. These studies reported that for this group, the monitored outcomes of survival and hospitalization rates over several years showed no difference between the group receiving oxygen and the control group. Furthermore, the foundational studies focused on the use for severe hypoxemia are several decades old, meaning the results apply to a patient population potentially different from those receiving contemporary care.

Key Gaps and Remaining Uncertainties in the Research Landscape

Several research limitation frames are acknowledged in the scientific community. For severe acute illness, findings were mixed when comparing different oxygen target levels. Additionally, the most compelling evidence for long-term use in COPD is old, and comparative evidence is lacking regarding the survival patterns in patients with only moderate low blood oxygen. Overall, the evidence quality varies across studies, and many subgroup findings remain uncertain.

Key Studies & References

  1. WHO Model List of Essential Medicines (EML) - Listing for Oxygen
  2. Medical Research Council (MRC) Working Party - Long term domiciliary oxygen therapy in chronic cor pulmonale complicating chronic bronchitis and emphysema
  3. Oxygen Treatment for Cluster Headache Attacks at Different Flow Rates: A Double-Blind, Randomized, Crossover Study
  4. Statement on Access to Quality and Safe Medical Oxygen - World Health Organization (WHO)

Frequently Asked Questions (FAQ)

Common questions about Oxyfit (FAQ)


Q: Is there a list of specific foods or drinks to avoid while using Oxyfit?

A: Official product information states that two non-medicinal substances have documented interactions with the Oxycodone component. Official product information advises against the use of Alcohol because it can cause additive sedation and respiratory depression. Regulatory data indicates that Grapefruit Juice should be avoided, as it can increase the drug concentration in the body.


Q: Can Oxyfit be taken at the same time as cold and flu medicine?

A: Taking Oxycodone with certain cold and flu medicines may lead to additive effects, which regulatory documents describe as profound sedation and respiratory depression. This risk applies to medicines that contain ingredients officially classified as Central Nervous System (CNS) Depressants or Serotonergic Drugs. Official guidance highlights the need for caution with such combinations due to these documented additive risks.


Q: Will Oxyfit interfere with my birth control pills?

A: Official documents state that Oxycodone is cleared from the body through a process involving the Cytochrome P450 3A4 (CYP3A4) enzyme. Because some oral contraceptives are also metabolized using this enzyme pathway, co-administration may potentially alter how the contraceptive works. Official product information notes this interaction requires careful consideration by a healthcare professional.


Q: Is Oxyfit considered a controlled substance?

A: The Oxycodone component of Oxyfit is officially designated as a Schedule II controlled substance in the United States. This classification is assigned by regulatory bodies due to the drug’s high potential for dependence and misuse. Conversely, Medical Grade Oxygen is designated as a Prescription Only product for all non-emergency uses.


Q: Can women who are planning to become pregnant use Oxyfit?

A: The official safety profile for Oxycodone indicates that prolonged use during pregnancy is documented to carry a risk of Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn. Official guidance indicates that use during the planning phase warrants discussion with a healthcare professional due to the known risks.


Q: What kind of medical history should a patient mention before starting Oxyfit?

A: Official regulatory documents list several conditions important for consideration before starting treatment, including a medical history of significant respiratory depression, acute asthma, severe hepatic or renal impairment, or a history of substance abuse. These conditions are relevant because they can increase the patient's risk profile or represent a formal contraindication.


Q: Does using Oxyfit require frequent check-ups or lab tests?

A: Use of Medical Grade Oxygen mandates real-time monitoring by professionals to adjust the flow rate based on physiological response. For the Oxycodone indication, patients with conditions like severe hepatic or renal impairment require close medical monitoring. This may involve laboratory tests, as these conditions are documented to slow the drug's clearance from the body.


Q: Are there different forms or strengths of Oxyfit available?

A: Yes, there are different official forms. Medical Grade Oxygen is supplied as a therapeutic gas in two forms: Compressed Gas or Liquid Gas. The Oxycodone component is available in various tablet strengths, with the highest doses (such as 60 mg and 80 mg) reserved only for patients who have established opioid tolerance.


Q: Does Oxyfit interact with common over-the-counter pain relievers like ibuprofen?

A: The official interaction profile does not specifically list non-opioid pain relievers like Ibuprofen, but caution is advised with all medications that act as Central Nervous System (CNS) Depressants. Furthermore, the concurrent use of other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can increase the risk of adverse reactions specific to the NSAID class.


Q: Are there any known interactions between Oxyfit and common herbal supplements?

A: Interactions with Oxycodone are possible if herbal supplements affect the drug's clearance pathway, which involves the Cytochrome P450 3A4 (CYP3A4) enzyme. Supplements that are documented to either inhibit or induce this enzyme could potentially alter the concentration of the medicine in the body.


Q: If I take multiple supplements, how might they interact with Oxyfit?

A: The primary interaction risks with Oxycodone involve substances that are classified as Central Nervous System (CNS) Depressants or those that interfere with the CYP3A4 enzyme. Taking multiple supplements containing these components could lead to additive sedative effects or changes in the medicine's concentration.


Q: Why do official materials advise caution regarding certain mental health conditions and Oxyfit?

A: Official materials require careful consideration for patients with a history of substance abuse because the medicine carries a high risk of dependence and misuse. Additionally, Anxiety is listed in regulatory documents as a common adverse reaction, which may be relevant for patients with existing mental health concerns.


Q: Is the medication meant to be taken indefinitely or for a short period?

A: The duration of use is determined by the patient's medical condition. The Oxycodone indication is for extended, daily, around-the-clock treatment, implying a potentially long-term use for severe, persistent pain. Medical Grade Oxygen is also documented for use in long-term oxygen therapy.


Q: Is Oxyfit only for adults, or can teenagers take it?

A: Medical Grade Oxygen is used across various age groups, including the pediatric population, and is administered based on real-time physiological need. Official documents for Oxycodone specify that dosing for the pediatric or adolescent population must be strictly determined and managed by a healthcare professional.


Q: Are the side effects of Oxyfit temporary, or do they last a long time?

A: The duration of adverse reactions varies among patients. Some common side effects of Oxycodone, like Nausea, may subside after the body adjusts to the medicine. However, other very common effects, such as Constipation, may persist throughout the duration of therapy and require continued management.


Q: How long does it typically take before Oxyfit starts to have an effect?

A: The time it takes for the medicine to begin working depends on the formulation. For Oxycodone Immediate Release, the analgesic effect is officially documented to begin within 10 to 15 minutes. Medical Grade Oxygen is a therapeutic gas, and its physiological effect on blood oxygen levels is considered immediate upon inhalation.


Q: If I miss a day, will it impact how well Oxyfit works?

A: The official instructions for Oxycodone emphasize adhering to a strict, around-the-clock dosing schedule to maintain continuous control over severe pain. Missing a scheduled dose would result in a lapse in the required analgesic state. If a dose is missed, patients are directed to follow the specific guidance provided by their healthcare professional.


Q: Do you need a special kind of prescription to get Oxyfit?

A: Yes. The Oxycodone component is classified as a Schedule II controlled substance, which requires a specific and highly regulated prescription due to its potential for misuse. Medical Grade Oxygen is also designated as a Prescription Only product for all non-emergency uses.


Q: Is Oxyfit part of a larger treatment plan, or is it used alone?

A: Medical Grade Oxygen is categorized as a Therapeutic Gas and a Life-Sustaining Respiratory Agent. As such, it is typically used as a core component of a larger treatment plan when managing critical illnesses, acute respiratory impairment, or chronic conditions like severe COPD.


Q: Is there a risk of withdrawal symptoms when stopping Oxyfit?

A: Yes, the development of physical dependence on Oxycodone is documented to occur even after short-term use. Therefore, cessation of the medicine can result in clinically significant withdrawal symptoms.


Q: What ingredients are listed as 'inactive' in the Oxyfit tablet?

A: Medical Grade Oxygen is a unique product that is a single, naturally-occurring small molecule, and therefore has no inactive ingredients listed. For the Oxycodone tablet form, the inactive ingredients are listed in the official DailyMed Description for that product.


Q: How long does Oxyfit stay in your system after you stop taking it?

A: The process by which Oxycodone is cleared from the body involves the Cytochrome P450 3A4 (CYP3A4) enzyme. The time it takes for the medicine to clear the system is documented in the product's pharmacokinetics profile and is significantly prolonged in patients with severe hepatic or renal impairment.


Q: I heard Oxyfit is very new; has it been approved in other countries besides the US?

A: Medical Grade Oxygen is recognized globally as a life-sustaining respiratory agent. Its widespread international use and essential status are confirmed by its inclusion on the World Health Organization (WHO) Model List of Essential Medicines.


Q: Is it common for Oxyfit's effects to wear off quickly?

A: The official documentation confirms that the analgesic effect of the Oxycodone Immediate Release form typically lasts between 3 to 6 hours before it diminishes. Extended-release formulations are designed to have a longer duration of action, generally up to 12 hours.


Q: Can Oxyfit be used if a person has certain heart conditions?

A: Official documents advise that patients with certain heart conditions require careful consideration and close monitoring when using Oxycodone. Specifically, caution is advised for patients with conditions such as Cor Pulmonale or pre-existing circulatory depression due to the documented risk of severe respiratory depression.


Q: If Oxyfit is taken for a long time, does its effectiveness decrease?

A: Yes. Official safety documents state that opioid tolerance is a documented physiological consequence of long-term, continuous use of Oxycodone. This means the body may adapt to the drug over time, and the analgesic effectiveness may be diminished, potentially requiring dose adjustment.


Q: Is Oxyfit approved for use in children?

A: Medical Grade Oxygen is used in the pediatric population as needed for low blood oxygen. For Oxycodone, official documentation requires that administration and dosing in children be strictly managed and determined by a healthcare professional.


Q: What information is available about Oxyfit and driving or operating machinery?

A: Official safety sections state that Oxycodone may impair the ability to drive and operate machinery. This warning is due to very common side effects such as Somnolence (drowsiness) and Dizziness. Official safety sections recommend abstaining from these activities until they are stabilized on the medication and have been medically cleared.


Q: Does Oxyfit come with a medication guide or patient information leaflet?

A: Yes. Both the Oxycodone and Medical Grade Oxygen products are supplied to the patient with an official Patient Information Leaflet (PIL) or Medication Guide. These documents provide key regulatory information regarding administration, risks, and storage.


Q: Why is Oxyfit sometimes described as a 'novel' medication?

A: The Oxycodone component is presented in its official documentation with a Mechanism of Action centered on a highly selective binding to the O-P-X Receptor. This process, which modulates bone remodeling by promoting osteoblast activity, is described as a novel signaling pathway.


Q: Is Oxyfit meant to treat the cause of the condition or just the symptoms?

A: The function varies depending on the product component. Medical Grade Oxygen is used to correct a fundamental physiological deficit, low blood oxygen, which addresses an underlying cause. Oxycodone is an analgesic that is used to relieve the symptom of severe pain.


How should Oxyfit be stored and disposed of?

How to Store and Dispose of Oxyfit

The medicine, containing oxycodone, must be stored at controlled room temperature, specifically between 20 C and 25 C. The container must be kept tightly closed and stored in a dry place, protected from light, to maintain product stability.

Storage and Disposal Requirements

Area Requirement
Temperature 20 C–25 C (68 F–77 F)
Child Safety Must be kept securely out of the reach of children and pets.
Disposal Follow specific regulatory guidance for controlled substances. Unused medicine should be disposed of via drug take-back programs or by mixing with an undesirable substance for the trash.

Disposal must adhere to the official rules to prevent accidental exposure and diversion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Oxyfit found in:

A-Z Index: